Salemonline Journal

Spine Pain Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

 Breaking News
  • No posts were found

Spine Pain Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market

November 08
18:16 2022
Spine Pain Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies Working in the market
DelveInsight Business Research LLP
DelveInsight’s ‘Spine Pain Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Spine Pain, historical and forecasted epidemiology as well as the AS market trends in the United States, U5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

DelveInsight’s Spine Pain Market Insights, Epidemiology, and Market Forecast–2032 report deliver an in-depth understanding of the Spine Pain, historical and forecasted epidemiology as well as the AS market trends in the United States, U5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

 

The Spine Pain market report provides current treatment practices, emerging drugs, and market share of individual therapies, current and forecasted 7MM market size from 2019 to 2032. The Report also covers current treatment practices, market drivers, market barriers, SWOT analysis, reimbursement, and market access, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

Some of the key facts of the Spine Pain Market Report:

  1. As per Manchikanti et al., the prevalence of facet joint pain in patients with chronic cervical spine pain was 55% (95% CI, 49% – 61%), with thoracic spine pain was 42% (95% CI, 30% – 53%), and in with lumbar spine pain was 31% (95% CI, 27% – 36%). The false-positive rate with single blocks with lidocaine was 63% (95% CI, 54% – 72%) in the cervical spine, 55% (95% CI, 39% – 78%) in the thoracic spine, and 27% (95% CI, 22% – 32%) in the lumbar spine.The initial medical treatment of spine pain commonly consists of non-steroidal anti-inflammatory (NSAIDs) medication if the pain is mild to moderate. Muscle relaxants and narcotic medication can be added or substituted for cases of more severe pain symptoms. In some cases physicians may recommend physical therapy.

  1. As per the DelveInsight estimates, in the US, the total number of diagnosed cases of Allergic rhinitis was around 30 M in 2021 which are expected to grow during the study period, i.e., 2019–2032.

  1. As per the DelveInsight estimates, in Germany, the total Age group-specific cases of Allergic rhinitis were around 0.69, 2.4, and 19 M in 2021 for age groups

Got queries? Click here to know more about the Spine Pain Market 

 

Spine Pain Overview

Pain arising from various structures of the spine constitutes the majority of the problems in chronic pain settings. Spine pain is generally of two types: the lumbar region (lower back) and cervical region (neck). Lumbar muscle strains and sprains are the most common causes of low back pain. The thoracic spine can also be a site of spinal pain, but because it is much more rigid, the thoracic spinal area is much less frequently injured than the lumbar and cervical spine. The lifetime prevalence of spinal pain has been reported as 54% to 80%. Spine Pain can range from a muscle aching to a shooting, burning or stabbing sensation. In addition, the pain may radiate down the legs or worsen with bending, twisting, lifting, standing or walking.

The lack of information about treatments by chiropractors, physical therapists, and other care providers results in underestimated cost estimates for treatment of low back pain. There is also a lack of information on medical procedures done in offices or surgeries, limiting estimates of cost and effectiveness of many interventional procedures, including many surgical procedures. These gaps in knowledge should be filled to obtain accurate estimates of the impact of back and neck pain on society.The dynamics of the Spine pain market is anticipated to experience a major positive shift in the coming years owing to the expected launch of major therapies. Research is underway to identify therapeutic targets and develop a curative therapy for the treatment of Spine pain. The current major pipeline candidates are as follows: AIN457, Fasinumab, STA363.

 

Spine Pain  Epidemiological Insight

 

  • As per Manchikanti et al., the prevalence of facet joint pain in patients with chronic cervical spine pain was 55% (95% CI, 49% – 61%), with thoracic spine pain was 42% (95% CI, 30% – 53%), and in with lumbar spine pain was 31% (95% CI, 27% – 36%). The false-positive rate with single blocks with lidocaine was 63% (95% CI, 54% – 72%) in the cervical spine, 55% (95% CI, 39% – 78%) in the thoracic spine, and 27% (95% CI, 22% – 32%) in the lumbar spine

  • According to Manchikanti et al., the annual prevalence estimates of any neck pain among adults ranged from 12.1% to 71.5% and among children, it ranged from 34.5% to 71.5%, with most estimates of annual prevalence between 30% and 50%. It has also been found that neck pain is more common in women (22%) than men (16%).

  • As per Leboeuf-Yde et al., the estimated prevalence of thoracic pain in 13% of the general population in contrast to 43% in the low back and 44% in the neck. 

 

Spine Pain Epidemiological Segmentation 

  •  Total Prevalent Cases of Spine pain

  •  Type-specific Prevalent Cases of Spine pain

  •  Age-specific cases of Spine pain 

  •  Gender-specific cases of Spine pain

Spine Pain Market Outlook 

The initial medical treatment of spine pain commonly consisted of non-steroidal anti-inflammatory (NSAIDs) medication if the pain is mild to moderate. Muscle relaxants and narcotic medication can be added or substituted for cases of more severe pain symptoms. In some cases physicians may recommend physical therapy. The therapist will perform an in-depth evaluation, which combined with the doctor’s diagnosis, will dictate a treatment specifically designed for patients with spinal pain. Therapy may include pelvic traction, gentle massage, ice and heat therapy, ultrasound, electrical muscle stimulation and stretching exercises. 

 

 

 

Spine Pain Key Companies

  •  Novartis

  • Regeneron Pharmaceuticals and others.

 

Spine Pain Therapies

  • NSAIDs 

  • Antiepileptic Drugs 

  • AIN457 (secukinumab)

 

Table of Contents

  •  Key Insights 

  •  Report Introduction 

  •  Executive Summary of Spine Pain 

  •  Disease Background and Overview

  •  Epidemiology and patient population

  •  The United States 

  •  EU 5

  • Spine Pain  Emerging Therapies

  •  Spine Pain Market Outlook

  •  Market Access and Reimbursement of Therapies

  •  Appendix

  •  Spine Pain Report Methodology

  •  DelveInsight Capabilities

  • Disclaimer

  •  About DelveInsight

Click here to read more about Spine Pain market

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles